Bharat Biotech's Covaxin Safe But Need Phase 3 Results to Assess Effectiveness, Says Lancet

The report also mentioned that Phase 2 results of Covaxin (codenamed BBV152) do not permit efficacy assessments and further validation with Phase 3 safety results was needed.

Latest News of India, Sports, Tech, Technology 2021 from Top India News- News18.com for more info CLICK HERE